Cargando…
Treatment of paediatric pontine glioma with oral trophosphamide and etoposide
To evaluate the overall survival of paediatric patients with pontine gliomas treated with oral trophosphamide and etoposide. Patients between 3 and 17 years of age with either typical diffuse pontine glioma on MRI or histologically proven anaplastic astrocytoma/glioblastoma multiforme located in the...
Autores principales: | Wolff, J E A, Westphal, S, Mölenkamp, G, Gnekow, A, Warmuth-Metz, M, Rating, D, Kuehl, J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364312/ https://www.ncbi.nlm.nih.gov/pubmed/12434281 http://dx.doi.org/10.1038/sj.bjc.6600552 |
Ejemplares similares
-
Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas
por: Wagner, S, et al.
Publicado: (2006) -
Cerebellar location may predict an unfavourable prognosis in paediatric high-grade glioma
por: Karremann, M, et al.
Publicado: (2013) -
A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report
por: Gnekow, Astrid K., et al.
Publicado: (2017) -
HGG-40. FOCUSED ULTRASOUND ENHANCES ETOPOSIDE DELIVERY IN A MURINE PONTINE GLIOMA MODEL
por: Englander, Zachary, et al.
Publicado: (2021) -
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study
por: Reardon, D A, et al.
Publicado: (2009)